---
title: Newsroom | Drug Discovery & Development (3)
description: Drug Discovery & Development |  (3)
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development>

 Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [GenNext Technologies and Thermo Fisher Scientific collaborate to simplify structural biology for faster biotherapeutic development](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development)

 May 7, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 7, 2025, 12:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)

#### [EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery)

 April 24, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 24, 2025, 5:11:09 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Indivumed celebrates milestone of its patient-centric R&D platform: Numerous novel cancer targets discovered for first-in-class therapeutics](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics)

 April 8, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 8, 2025, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962)

 January 8, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 8, 2025, 1:13:03 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Synexa Life Sciences expands bioanalysis capabilities with the acquisition of CRO Alderley Analytical](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical)

 October 7, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 7, 2024, 9:00:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/qubit-pharmaceuticals-nominated-for-best-start-up-2024-award-by-prix-galien-usa>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Qubit Pharmaceuticals nominated for "Best start-up 2024" award by Prix Galien USA](https://news.lifesciencenewswire.com/newsroom/qubit-pharmaceuticals-nominated-for-best-start-up-2024-award-by-prix-galien-usa)

 August 20, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/qubit-pharmaceuticals-nominated-for-best-start-up-2024-award-by-prix-galien-usa)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/qubit-pharmaceuticals-nominated-for-best-start-up-2024-award-by-prix-galien-usa#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 20, 2024, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/icosagen-and-lead-discovery-center-announce-collaboration-to-discover-novel-monoclonal-antibodies>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)

#### [Icosagen and Lead Discovery Center announce collaboration to discover novel monoclonal antibodies](https://news.lifesciencenewswire.com/newsroom/icosagen-and-lead-discovery-center-announce-collaboration-to-discover-novel-monoclonal-antibodies)

 May 15, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/icosagen-and-lead-discovery-center-announce-collaboration-to-discover-novel-monoclonal-antibodies)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/icosagen-and-lead-discovery-center-announce-collaboration-to-discover-novel-monoclonal-antibodies#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 15, 2024, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/the-university-of-edinburgh-acknowledges-pelago-patent-and-use-of-cetsa-process>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [The University of Edinburgh acknowledges Pelago patent and use of ​CETSA® process](https://news.lifesciencenewswire.com/newsroom/the-university-of-edinburgh-acknowledges-pelago-patent-and-use-of-cetsa-process)

 February 27, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/the-university-of-edinburgh-acknowledges-pelago-patent-and-use-of-cetsa-process)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/the-university-of-edinburgh-acknowledges-pelago-patent-and-use-of-cetsa-process#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 27, 2024, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/horizon-cme-announces-first-annual-summit-for-novel-therapeutics-in-oncology-precision-medicine-in-cancer-stop-cancer>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Horizon CME announces first annual summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)](https://news.lifesciencenewswire.com/newsroom/horizon-cme-announces-first-annual-summit-for-novel-therapeutics-in-oncology-precision-medicine-in-cancer-stop-cancer)

 February 20, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/horizon-cme-announces-first-annual-summit-for-novel-therapeutics-in-oncology-precision-medicine-in-cancer-stop-cancer)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/horizon-cme-announces-first-annual-summit-for-novel-therapeutics-in-oncology-precision-medicine-in-cancer-stop-cancer#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 20, 2024, 12:00:00 PM

- [Tweet](https://twitter.com/share)

[Previous](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/2) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/4)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance>

#### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

 October 6, 2026

Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development>

#### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 October 5, 2026

Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development>

#### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

 October 1, 2026

The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)